Advances in glucocorticoid therapy.
Baxter
J D
JD
Metabolic Research Unit, University of California, San Francisco, USA.
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000287:Administration, Topical; D000324:Adrenocorticotropic Hormone / Q000187:drug effects; D004338:Drug Combinations; D004351:Drug Resistance; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007239:Infections; D010024:Osteoporosis / Q000139:chemically induced; D010913:Pituitary-Adrenal System / Q000187:drug effects; D018160:Receptors, Cytoplasmic and Nuclear / Q000187:drug effects
D004338:Drug Combinations; D005938:Glucocorticoids; D018160:Receptors, Cytoplasmic and Nuclear; D000324:Adrenocorticotropic Hormone